DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Semapimod is an investigational drug.
There have been 5 clinical trials for Semapimod. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2002.
The most common disease conditions in clinical trials are Crohn Disease and [disabled in preview]. The leading clinical trial sponsors are Ferring Pharmaceuticals and [disabled in preview].
Recent Clinical Trials for Semapimod
|Single Ascending Dose Study of Oral CPSI-2364 (Semapimod)||Ferring Pharmaceuticals||Phase 1|
|Extension Study of Semapimod 60 mg IV x 3 Days||Ferring Pharmaceuticals||Phase 2|
|Long-term Study of Semapimod (CNI-1493) for Treatment of Crohn's Disease||Ferring Pharmaceuticals||Phase 2|